Adjuvant chemotherapy outcomes of node negative, T1a, T1b, T1c hormone receptor-negative HER2-positive breast cancer patients

被引：0
|
作者：
Paul, Anu
Shi, Runhua
Peddi, Prakash
Burton, Gary
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-2761
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2761
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Outcomes of radical prostatectomy for patients with clinical stage T1a and T1b disease
    Helfand, Brian T.
    Mongiu, Anne K.
    Kan, Donghui
    Kim, Dae-Yun
    Loeb, Stacy
    Roehl, Kimberly A.
    Meeks, Joshua J.
    Smith, Norm D.
    Catalona, William J.
    BJU INTERNATIONAL, 2009, 104 (03) : 304 - 309
  • [42] Effect of lymphatic mapping on diagnosis and treatment of patients with T1a, T1b favorable breast cancer
    Jakub, JW
    Ebert, MD
    Diaz, NM
    Cantor, A
    Reintgen, DS
    Dupont, EL
    Shons, AR
    Cox, CE
    ANNALS OF SURGERY, 2003, 237 (06) : 838 - 843
  • [43] Recurrence risk in T1a-b, node negative, HER2 positive breast cancer.
    Black, D.
    Younger, J.
    Martei, Y.
    Michaelson, J.
    Dominguez, F.
    Bhan, A.
    Burstein, H.
    Winer, E.
    Goss, P.
    Smith, B.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S92 - S93
  • [44] Comparative survival outcomes of neoadjuvant and adjuvant therapy in patients with T1c, node-negative, triple-negative breast cancer: A population-based analysis
    Zheng, Yi-Zi
    Ying, Jia-Qi
    Wu, Ting-Ting
    Su, Yong-Hui
    Wang, Ou-Chen
    BREAST, 2025, 79
  • [45] Assessment of Use and Impact of Chemotherapy in Lymph Node-Negative, T1a Triple-Negative Breast Cancer
    Bravo-Solarte, Daniela C.
    Zhang, Frank
    Anampa, Jesus D.
    CLINICAL BREAST CANCER, 2023, 23 (07) : 763 - 773.e6
  • [46] Outcomes of patients with T1a,b N0 Her2-positive breast cancer treated with adjuvant trastuzumab in a prospective registry in Ontario, Canada.
    Eisen, Andrea
    Gill, Tripat
    Habbous, Steven
    Beca, Jaclyn M.
    Arias, Jessica
    Chan, Kelvin K.
    Trudeau, Maureen E.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [47] DECRESCENDO: de-escalating chemotherapy in HER2-positive, estrogen receptor-negative, node-negative early breast cancer
    Debien, Veronique
    Adam, Virginie
    Coart, Elisabeth
    Agostinetto, Elisa
    Goulioti, Theodora
    Molinelli, Chiara
    Arahmani, Amal
    Zoppoli, Gabriele
    Piccart, Martine
    FUTURE ONCOLOGY, 2023, 19 (24) : 1655 - 1667
  • [48] What is the most common mammographic appearance of T1a and T1b invasive breast cancer?
    Podkrajsek, Maja
    Zgajnar, Janez
    Hocevar, Marko
    RADIOLOGY AND ONCOLOGY, 2008, 42 (04) : 173 - 180
  • [49] Outcomes in postmenopausal women with hormone receptor positive, HER-2 negative T2N0 breast cancer without adjuvant chemotherapy
    Kim, Y. S.
    Ko, B. S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [50] Role of adjuvant therapy in resected stage IA subcentimeter (T1a/T1b) pancreatic cancer
    Shaib, Walid L.
    Narayan, Amit Surya
    Switchenko, Jeffrey M.
    Kane, Sujata R.
    Wu, Christina
    Akce, Mehmet
    Alese, Olatunji B.
    Patel, Pretesh R.
    Maithel, Shishir K.
    Sarmiento, Juan M.
    Kooby, David A.
    El-Rayes, Bassel F.
    CANCER, 2019, 125 (01) : 57 - 67
12345